Mechanism of inhibition of a poxvirus topoisomerase by the marine natural product sansalvamide A

Molecular Pharmacology

Volumn 55, Issue 6, 1999, Pages 1049-1053

  Hwang, Young ^a   Rowley, David ^a,b   Rhodes, Denise ^a   Gertsch, Jeff ^a   Fenical, William ^b   Bushman, Frederic ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; NATURAL PRODUCT; SANSALVAMIDE A; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; COMPLEX FORMATION; DNA BINDING; DNA MODIFICATION; DNA NICK TRANSLATION; ENZYME ASSAY; ENZYME INHIBITION; MOLLUSCUM CONTAGIOSUM; NONHUMAN; POXVIRUS; PRIORITY JOURNAL;

EID: 0032977819     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.55.6.1049     Document Type: Article

References (24)

1. Amidon GL and Lee HJ (1994) Absorption of peptide and peptidomimetic drugs. Annu Rev Pharmacol Toxicol 34:321-341.
2. Blackburn RK and Van Breemen RB (1993) Application of an immobilized digestive enzyme assay to measure chemical and enzymatic hydrolysis of the cyclic peptide antibiotic lysobactin. Drug Metab Dispos 21:573-579.
3. Borel JF, Feurer C, Gubler HU and Stahelin H (1976) Biological effects of cyclosporin A: A new antilymphocytic agent. Agents Actions 6:468-475.
4. Davidson BS (1995) New dimensions in natural product research: Cultured marine microorganisms. Curr Opin Biotechnol 6:284-291.
5. Eichler J, Lucka AW, Pinilla C and Houghten RA (1995) Novel alpha-glucosidase inhibitors identified using multiple cyclic peptide combinatorial libraries. Mol Divers 1:233-240.
6. Fusetani N, Matsunaga S, Matsumoto H and Takebayashi Y (1990) Cyclotheonamides, potent thrombin inhibitors, from a marine sponge Theonella sp. J Am Chem Soc 112:7053-7054.
7. Giebel LB, Cass RT, Milligan DL, Young DC, Arze R and Johnson CR (1995) Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities. Biochemistry 34:15430-15435.
8. Gottlieb SL and Myskowski PL (1994) Molluscum contagiosum. Int J Dermatol 33:453-461.
9. Gupta M, Fujimori A and Pommier Y (1995) Eukaryotic DNA topoisomerases I. Bio Biophys Acta 1262:1-14.
10. Hansen MST, Carteau S, Hoffmann C, Li L and Bushman F (1998) Retroviral cDNA integration: Mechanism, applications and inhibition, in Genetic Engineering, Principles and Methods (Setlow JK ed) pp 41-62, Plenum Press, New York.
11. Hwang Y, Wang B and Bushman FD (1998) Molluscum contagiosum virus topoisomerase: Purification, activities and response to inhibitors. J Virol 72:3401-3406.
12. Ireland CM, Durso AR, Newman RA and Hacker MP (1982) Antineoplastic cyclic peptides from the marine tunicate Lissoclinum patella. J Org Chem 47:1807-1811.
13. Jensen PR and Fenical W (1994) Strategies for the discovery of secondary metabolites from marine bacteria: Ecological perspectives. Annu Rev Microbiol 48:559-584.
14. Pauletti GM, Gangwar S, Okumu FW, Siahaan TJ, Stella VJ and Borchardt RT (1996) Esterase-sensitive cyclic prodrugs of peptides: Evaluation of an acyloxylalkoxy promoiety in a model hexapeptide. Pharm Res (NY) 13:1615-1623.
15. Petersen CS and Gerstoft J (1992) Molluscum contagiosum in HIV-infected patients. Dermatology 184:19-21.
16. Porter CD, Blake NW, Cream JJ and Archard LC (1992) Molluscum contagiosum virus, in Molecular and Cell Biology of Sexually Transmitted Diseases (D. a. A. Wright L., ed) pp 223-257, Chapman and Hall, London.
17. Rinehart KL, Kishore V, Bible KC, Sakai R, Sullins DW and Li KM (1988) Didemnins and tunichlorin: Novel natural products from the marine tunicate Trididemnum solidum. J Nat Prod 51:1-21.
18. Sakai R, Rinehart KL, Kishore V, Kundu B, Faircloth G, Gloer JB, Carney JR, Namikoshi M, Sun F, Hughes RG, Gravalos DG, Quesada TG, Wilson GR and Heid RM (1996) Structure-activity relationships of the didemnins. J Med Chem 39: 2819-2834.
19. Schwartz JJ and Myskowski PL (1992) Molluscum contagiosum in patients with human immunodeficiency virus infection. J Am Acad Dermatol 27:583-588.
20. Senkevich TG, Bugert JJ, Sisler JR, Koonin EV, Darai G and Moss B (1996) Genome sequence of a human tumorigenic poxvirus: Prediction of specific host response-evasion genes. Science (Wash DC) 273:813-816.
21. Shuman S, Golder M and Moss B (1989) Insertional mutagenesis of the vaccinia virus gene encoding a type I DNA topoisomerase: Evidence that the gene is essential for virus growth. Virology 170:302-306.
22. Strohl WR (1997) Biotechnology of Antibiotics. Marcel Dekker, Inc., New York.
23. Wang JC (1996) DNA topoisomerases. Annu Rev Biochem 65:635-692.
24. Wenger RM (1986) Synthesis of cyclosporin and analogues: Structural and conformational requirements for immunosuppressive activity. Prog Allergy 38:46-64.